Beyond renal response: sustained systemic disease control protects against adverse long-term outcomes in lupus nephritis

Konstantinos Drougkas, Spyridon Katechis, Myrto Kostopoulou, Christina Tsalapaki, Sofia Flouda, Maria Pappa, Marija Bakula, Ivan Padjen, Myrto Nikoloudaki, Pinelopi Konstantopoulou, George Moustakas, Dimitrios Vassilopoulos, George Bertsias, Paraskevi V Voulgari, Dimitrios T Boumpas, Antonis Fanouri · 2026

Read Beyond renal response: sustained systemic disease control protects against adverse long-term outcomes in lupus nephritis by Konstantinos Drougkas, Spyridon Katechis, Myrto Kostopoulou, Christina Tsalapaki, Sofia Flouda, Maria Pappa, Marija Bakula, Ivan Padjen, Myrto Nikoloudaki, Pinelopi Konstantopoulou, George Moustakas, Dimitrios Vassilopoulos, George Bertsias, Paraskevi V Voulgari, Dimitrios T Boumpas, Antonis Fanouri (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13218096.txt.

Description

Konstantinos Drougkas and colleagues ask, in a 2026 cohort study, whether controlling lupus body-wide protects the kidneys long term. Lupus nephritis is kidney inflammation caused by systemic lupus, and treatment success is usually judged by the kidney response alone. Two treat-to-target states used in general lupus care, a low disease activity state and full remission, were untested in this kidney group.

The multicentre study followed 155 patients with biopsy-proven kidney disease and a renal response already achieved, across 1,703 clinic visits. About 82 percent reached the modified low activity state and about 59 percent reached modified remission over a median 3.5 years of follow-up. Reaching either state was tied to large reductions in organ damage and kidney flare risk. Staying in the state for 2 years or more strengthened the protection. Reaching the target early helped as well, which supports treating the whole disease, not only the kidney.

Catalog record

CREATORKonstantinos Drougkas, Spyridon Katechis, Myrto Kostopoulou, Christina Tsalapaki, Sofia Flouda, Maria Pappa, Marija Bakula, Ivan Padjen, Myrto Nikoloudaki, Pinelopi Konstantopoulou, George Moustakas, Dimitrios Vassilopoulos, George Bertsias, Paraskevi V Voulgari, Dimitrios T Boumpas, Antonis Fanouri
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13218096

Browse the full library · About the Tower of Babel